SCVM - Scivanta Medical Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development--3.115
Selling General and Administrative236.273426.168322.725
Non Recurring--80.656-68.05
Total Operating Expenses---
Operating Income or Loss-236.273-345.512-257.79
Income from Continuing Operations
Total Other Income/Expenses Net---
Earnings Before Interest and Taxes-236.273-345.512-257.79
Interest Expense70.93578.86932.709
Income Before Tax-307.208-424.381-290.499
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-307.208-424.381-290.499
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-307.208-424.381-290.499
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-307.208-424.381-290.499